MLchartDataset catalogue

Fluorine F 18 RD2

Term · Oncology and biomedicine · MLC-T-ONC-013696

A radioconjugate composed of the amyloid-beta-binding peptide RD2 labeled with the radionuclide fluorine F 18, with potential amyloid-beta peptide imaging activity upon positron emission topography (PET)/computed tomography (CT). Upon administration of fluorine F 18 RD2, RD2 targets and binds to amyloid-beta. Upon PET/CT imaging, amyloid-beta plaques can be visualized and detected. Amyloid-beta is a key component in plaque formation in Alzheimer's disease. Elevated plasma levels of amyloid-beta are also associated with some cancers.

Table 1. Record
IdentifierMLC-T-ONC-013696
FieldOncology and biomedicine
Synonyms18F RD2; 18F-RD2; 18F-labeled RD2
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013696",
  "term": "Fluorine F 18 RD2",
  "field": "Oncology and biomedicine",
  "definition": "A radioconjugate composed of the amyloid-beta-binding peptide RD2 labeled with the radionuclide fluorine F 18, with potential amyloid-beta peptide imaging activity upon positron emission topography (PET)/computed tomography (CT). Upon administration of fluorine F 18 RD2, RD2 targets and binds to amyloid-beta. Upon PET/CT imaging, amyloid-beta plaques can be visualized and detected. Amyloid-beta is a key component in plaque formation in Alzheimer's disease. Elevated plasma levels of amyloid-beta are also associated with some cancers.",
  "synonyms": [
    "18F RD2",
    "18F-RD2",
    "18F-labeled RD2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/fluorine-f-18-rd2/"
}

Record 7,445 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.